• Explore /
  • Poster
  • / Phase II randomized trial of toremifene 120 mg compared with exemestane 25 mg after prior nonsteroidal aromatase inhibitor in postmenopausal women with hormone receptor-positive breast cancer.

Phase II randomized trial of toremifene 120 mg compared with exemestane 25 mg after prior nonsteroidal aromatase inhibitor in postmenopausal women with hormone receptor-positive breast cancer.

Abstract Poster

Authors

null

Hirotaka Iwase

Kumamoto University

Hirotaka Iwase , Yutaka Yamamoto , Takashi Ishikawa , Yasuo Hozumi , Masahiko Ikeda , Hiroji Iwata , Hiroko Yamashita , Tatsuya Toyama , Takashi Chishima , Izo Kimijima , Mutsuko Ibusuki , Shigehira Saji

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2012 Breast Cancer Symposium

Session Type

Poster Session

Session Title

General Poster Session B

Track

Survivorship and Health Policy,Systemic Therapy,Local/Regional Therapy

Sub Track

Advanced Disease

Clinical Trial Registration Number

UMIN000001841

Citation

J Clin Oncol 30, 2012 (suppl 27; abstr 105)

DOI

10.1200/jco.2012.30.27_suppl.105

Abstract #

105

Poster Bd #

B4

Abstract Disclosures

Similar Posters

First Author: Maysa M. Abu-Khalaf

First Author: Mario Campone

First Author: Pamela Klein

First Author: Tomás Pascual